AbbVie’s (ABBV) sBLA for Botox Gets Acceptance From FDA

ABBV announced that the FDA has accepted its supplemental biologics license application (sBLA) seeking approval of its blockbuster product, Botox, for a new indication. The company is looking to get …
( read original story …)


Advertisement